Cardio IQ™ LPA Aspirin Genotype

The Cardio IQ™ LPA Aspirin Genotype test contains 1 test with 3 biomarkers.

This test identifies individuals who are at risk of having elevated plasma lipoprotein (a) [Lp (a)] and increased cardiovascular risk which could be reduced by low-dose aspirin therapy.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: Apolipoprotein(a) gene polymorphism, Cardio IQ LPA Aspirin Genotype , LPA 4399Met genotype, LPA Aspirin Genotype, LPA Aspirin Genotype Cardio IQ

Reviewer

General Guidance

Method